Home > Products > CD317 & CD16
> Anti-CD317 x Anti-CD16 Bispecific Antibody (IgG-IgG)
Anti-CD317 x Anti-CD16 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-111)
Anti-CD317 x Anti-CD16 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD317 and anti-CD16 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Multiple myeloma (MM) therapy.
There are currently no customer reviews or questions for Anti-CD317 x Anti-CD16 Bispecific Antibody (IgG-IgG) (BSIG-111). Click the button below to contact us or submit your feedback about this product.